1. Home
  2. VVOS vs SABS Comparison

VVOS vs SABS Comparison

Compare VVOS & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VVOS
  • SABS
  • Stock Information
  • Founded
  • VVOS 2016
  • SABS 2014
  • Country
  • VVOS United States
  • SABS United States
  • Employees
  • VVOS N/A
  • SABS N/A
  • Industry
  • VVOS Medical Specialities
  • SABS Biotechnology: Pharmaceutical Preparations
  • Sector
  • VVOS Health Care
  • SABS Health Care
  • Exchange
  • VVOS Nasdaq
  • SABS Nasdaq
  • Market Cap
  • VVOS 14.8M
  • SABS 15.8M
  • IPO Year
  • VVOS 2020
  • SABS N/A
  • Fundamental
  • Price
  • VVOS $3.04
  • SABS $1.85
  • Analyst Decision
  • VVOS Strong Buy
  • SABS Strong Buy
  • Analyst Count
  • VVOS 2
  • SABS 6
  • Target Price
  • VVOS $6.10
  • SABS $11.17
  • AVG Volume (30 Days)
  • VVOS 75.7K
  • SABS 42.7K
  • Earning Date
  • VVOS 05-15-2025
  • SABS 05-27-2025
  • Dividend Yield
  • VVOS N/A
  • SABS N/A
  • EPS Growth
  • VVOS N/A
  • SABS N/A
  • EPS
  • VVOS N/A
  • SABS N/A
  • Revenue
  • VVOS $15,031,000.00
  • SABS $377,835.00
  • Revenue This Year
  • VVOS $17.40
  • SABS N/A
  • Revenue Next Year
  • VVOS $20.89
  • SABS $50.00
  • P/E Ratio
  • VVOS N/A
  • SABS N/A
  • Revenue Growth
  • VVOS 8.91
  • SABS N/A
  • 52 Week Low
  • VVOS $1.91
  • SABS $1.00
  • 52 Week High
  • VVOS $6.28
  • SABS $5.01
  • Technical
  • Relative Strength Index (RSI)
  • VVOS 58.97
  • SABS 60.23
  • Support Level
  • VVOS $2.50
  • SABS $1.67
  • Resistance Level
  • VVOS $3.33
  • SABS $2.15
  • Average True Range (ATR)
  • VVOS 0.21
  • SABS 0.18
  • MACD
  • VVOS 0.08
  • SABS 0.03
  • Stochastic Oscillator
  • VVOS 65.14
  • SABS 57.75

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

Share on Social Networks: